Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years.

ABSTRACT:

Importance

Accurate representation of racial and ethnic population subgroups in clinical trials is fundamental to ensure universal effectiveness of new therapies as well as to decrease disparities in oncology care.

Objective

To determine whether Hispanic people are underrepresented in Phase I and II clinical trials for liver cancer in the United States.

Participants

A database search was performed in clinicaltrials.gov for interventional liver cancer studies based only in the US with reported results from September 1, 2002, to February 1, 2023. A total of 37 trials with 963 total patients met inclusion criteria and were included for further analysis. Proportion of total patients by race/ethnicity was calculated for non-Hispanic white, non-Hispanic black, Asian, Hispan

SUBMITTER: Monge C 

PROVIDER: S-EPMC10807616 | biostudies-literature | 2023 Dec

REPOSITORIES: biostudies-literature